FDA Approvals in Oncology: April-June 2024
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with...